Annals Consult Guys - Should Your Patient's Surgery Be Stopped for Hypertension? The Pressure Is On
Authors: Geno J. Merli, Howard H. Weitz
Journal: Annals of Internal Medicine (2018)

Web Exclusives16 October 2018Annals Consult Guys - Should Your Patient's Surgery Be Stopped for Hypertension? The Pressure Is OnFREEGeno J. Merli, MD, Howard H. Weitz, MDGeno J. Merli, MDThomas Jefferson University, Philadelphia, Pennsylvania (G.J.M., H.H.W.)Search for more papers by this author, Howard H. Weitz, MDThomas Jefferson University, Philadelphia, Pennsylvania (G.J.M., H.H.W.)Search for more papers by this authorAuthor, Article and Disclosure Informationhttps://doi.org/10.7326/W18-0025 CME/MOC SectionsSupplemental MaterialAboutVisual Abstract ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In this episode of the consultative medicine talk show, the Consult Guys dissect the evidence regarding whether and when surgery should be delayed because of hypertension.For more videos from and information on Annals Consult Guys, visit go.annals.org/ConsultGuys. Comments0 CommentsSign In to Submit A Comment Royce Morrison MDClinical research safety consultant27 April 2020 What significance BP in pre-op setting? Dear Guys, It seems to me the discussion could usefully include comment on what immediately pre-op BP represents. In this patient, on a continuing regimen of BP medication that provided good BP control when recently seen in the office setting, it seems appropriate to attribute the pre-op BP elevation to stress of anticipation, of getting to the surgical site on time, etc. If there were no recent history of good BP, we would have less reason to provisionally attribute elevated BP to situational stress. In either case, instead of attempting BP control with usual antihypertensive drug(s), is there experience-based literature to suggest that treating anxiety (e.g., with a little IV midazolam) may quickly improve BP and provide reassurance? Thank you! Author, Article and Disclosure InformationDisclosures: Geno J. Merli, MD, reports the following: Research grants/contracts: Bristol-Myers Squibb, Bayer. Howard H. Weitz, MD, reports that he has no financial relationships or interests to disclose.Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Proctor & Gamble, Pfizer, and Johnson & Johnson. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 16 October 2018Volume 169, Issue 8Page: CG1KeywordsDiagnostic techniquesSurgeryResearch reporting guidelinesDisclosureResearch grantsHypertension ePublished: 16 October 2018 Issue Published: 16 October 2018 CopyrightCopyright © 2018 by American College of Physicians. All Rights Reserved.Loading ...